510(k) K011348— PHASE II GBM IGG ANTIBODY EIA TEST

Substantially Equivalent

Scimedx Corp.

Clearance details

Applicant: Scimedx Corp.
Product code: Code MVJ
Advisory panel: Immunology
Date received: 2001-05-02
Decision date: 2001-06-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Denvill, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.